High dose-rate (HDR) brachytherapy involves delivery of a high dose of radiation to the
cancer with great sparing of surrounding organs at risk. Prostate cancer is thought to be …

Brachytherapy has become an essential pillar in all-stages of localized prostate cancer,
where dose escalation has been demonstrated to improve outcome. HDR brachytherapy …

Abstract Background and Purpose High dose-rate (HDR) brachytherapy as a monotherapy
is an accepted treatment for localized prostate cancer, but the optimal dose and fractionation …

Purpose To jointly update the Cancer Care Ontario guideline on brachytherapy for patients
with prostate cancer to account for new evidence. Methods An Update Panel conducted a …

Purpose To update outcome and toxicity results of a prospective trial of 19-Gy single-fraction
high-dose-rate (HDR) brachytherapy for men with low-and intermediate-risk prostate cancer …

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study
assessing the efficacy and safety of a single-dose SBRT for men with localized prostate …

Purpose To evaluate acute and late genitourinary toxicity, the gastrointestinal toxicity, and
the long-term biochemical control after high-dose-rate (HDR) monotherapy in one fraction …

The aim of this article is to review and present the published data on high dose rate (HDR)
brachytherapy as monotherapy in the treatment of localised prostate cancer. A search and …

Background The aim of this systematic review is to assess the impact of primary treatments
with curative intention in patients with localized prostate cancer, measured with Patient …

Following adoption of moderately hypofractionated radiotherapy as a standard for localised
prostate cancer, ultrahypofractioned radiotherapy delivered in five to seven fractions is …